Page last updated: 2024-08-21

benzoxazoles and Hyperplasia

benzoxazoles has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aikawa, E; Aikawa, M; Goettsch, C; Hutcheson, JD; Iwata, H; Jaffer, FA; Libby, P; Matamalas, J; Mattson, PC; Mauskapf, A; Murakami, K; Osborn, EA; Singh, SA; Tearney, GJ; Ughi, GJ	1

Other Studies

1 other study(ies) available for benzoxazoles and Hyperplasia

Article	Year
Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging. Journal of the American Heart Association, 2021, 10-19, Volume: 10, Issue:20 Topics: Animals; Benzoxazoles; Butyrates; Constriction, Pathologic; Coronary Artery Disease; Hyperplasia; Inflammation; Neointima; PPAR alpha; Stents; Swine	2021

Article

Year

Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging.

Journal of the American Heart Association, 2021, 10-19, Volume: 10, Issue:20

Topics: Animals; Benzoxazoles; Butyrates; Constriction, Pathologic; Coronary Artery Disease; Hyperplasia; Inflammation; Neointima; PPAR alpha; Stents; Swine

2021